Rheumatologists who are outstanding clinicians, provide consistently exceptional care to patients and serve as role models for colleagues and trainees are in the spotlight in our Lessons from a Master Clinician series. Here, we offer insights from clinicians who have achieved a level of distinction in the field of rheumatology. Gary Hoffman, MD, MS, MACR,…
Polyarteritis nodosa (PAN) is a necrotizing vasculitis, predominantly involving medium-sized arteries, that causes systemic disease, and, less commonly, cutaneous-limited disease. The population prevalence for PAN ranges from 2 to 33 per million.1-3 Estimates vary due to the increased recognition and classification of other forms of vasculitides over time and variation in the regional prevalence of…
ATLANTA—The ACR released a summary of its updated guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis in September. Many patients take glucocorticoids for a variety of inflammatory conditions, and anyone who is taking glucocorticoid medications and has other risk factors for osteoporosis increases their risk of developing glucocorticoid-induced osteoporosis. New osteoporosis medications and new…
William Osler, MD, had an idea. Many institutions lay claim to the legacy of Osler, and by the time he arrived at Johns Hopkins Hospital in 1889 to become the first physician in chief of the institution, he was already widely acknowledged for his clinical acumen. He now wanted to spread that clinical acumen around.1…
Belimumab is now FDA approved to treat children aged 5 years and older with active lupus nephritis, providing treatment options for pediatric patients at risk of developing renal damage.
The society is helping Maryland rheumatologists navigate the state’s unique healthcare financing model, which sets statewide rates for all insurers for any service provided at hospitals.
Rheumatologists should take an active role in patients’ reproductive health, including before, during and after pregnancy. Two experts offer insights into how rheumatologists can better care for their patients during these critical times.
The increased use of telemedicine that began in 2020 at the start of the COVID-19 pandemic will continue to provide new ways to expand patient care in rheumatology.
The 2017 recommendations are updated to reflect changes in medical literature, as well as to include newly approved drugs.
Although progress has been made in recent years, rheumatologists still have a lot of questions regarding best management practices for antiphospholipid syndrome (APS). During a session of EULAR 2022, Ricard Cervera, MD, PhD, described a holistic approach.